Inquire Before Buying
Speak to an Analyst 
Request Brochure 
Request CustomizationIMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
Read More
Diabetes Drugs and Diagnostics Market Report by Segment (Oral Antidiabetics, Insulin, Diabetes Diagnostics), and Region 2024-2032
Report Format: PDF+Excel | Report ID: SR112024A2034
Buy Now
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Diabetes Disease Overview
4.1 What is Diabetes?
4.2 Diabetes Diagnosis and Treatment
4.2.1 Diagnosis
4.2.2 Treatment
4.3 Diabetes Complications
5 Key Factors Driving the Global Diabetes Market
6 Global Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
7 Global Diabetes Drugs and Diagnostics Market
7.1 Historical Market Trends
7.2 Market Breakup by Segment
7.3 Market Breakup by Region
7.4 Market Forecast
7.5 Top Selling Diabetes Drugs
7.5.1 Lantus (Sanofi)
7.5.2 Januvia (Merck And Co)
7.5.3 Humalog (Eli Lily and Co)
7.5.4 Novorapid/Novolog (Novo Nordisk)
7.5.5 Levemir (Novo Nordisk)
7.5.6 Victoza (Novo Nordisk)
7.5.7 Janumet (Merck And Co.)
7.5.8 Humulin (Eli Lily and Co.)
7.5.9 Toujeo (Sanofi)
7.6 SWOT Analysis
7.6.1 Overview
7.6.2 Strengths
7.6.3 Weaknesses
7.6.4 Opportunities
7.6.5 Threats
7.7 Value Chain Analysis
7.8 Porter’s Five Forces Analysis
7.8.1 Overview
7.8.2 Bargaining Power of Buyers
7.8.3 Bargaining Power of Suppliers
7.8.4 Degree of Competition
7.8.5 Threat of New Entrants
7.8.6 Threat of Substitutes
8 Market by Segment
8.1 Global Oral Antidiabetics Market
8.1.1 Historical Market Trends
8.1.2 Market Breakup by Class
8.1.2.1 Biguanides
8.1.2.2 Alpha-Glucosidase Inhibitors
8.1.2.3 Sodium-Glucose Cotransport -2 Inhibitors (SGLT-2 Inhibitors)
8.1.2.4 Dipeptidyl Peptidase-4 Inhibitors (DPP-4 Inhibitors)
8.1.2.5 Sulfonylureas
8.1.2.6 Dopamine -D2 Receptor Agonist
8.1.2.7 Others
8.1.3 Key Players
8.1.4 Market Outlook
8.2 Global Insulin Market
8.2.1 Historical Market Trends
8.2.2 Market Breakup by Class
8.2.2.1 Long Acting Insulin
8.2.2.2 Fast Acting Insulin
8.2.2.3 Short Acting
8.2.2.4 Others
8.2.3 Key Players
8.2.4 Market Outlook
8.3 Global Diabetes Diagnostics Market
8.3.1 Historical Market Trends
8.3.2 Market Breakup by Product Type
8.3.2.1 Blood Glucose Meters
8.3.2.2 Blood Glucose Strips
8.3.2.3 Lancets
8.3.3 Market Breakup by End-User
8.3.3.1 Hospitals and Clinics
8.3.3.2 Home Healthcare
8.3.3.3 Ambulatory Care Centers
8.3.3.4 Others
8.3.4 Key Players
8.3.5 Market Outlook
9 Market by Region
9.1 North America
9.1.1 Historical Market Trends
9.1.2 Market Outlook
9.2 Europe
9.2.1 Historical Market Trends
9.2.2 Market Outlook
9.3 Asia Pacific
9.3.1 Historical Market Trends
9.3.2 Market Outlook
9.4 Middle East and Africa
9.4.1 Historical Market Trends
9.4.2 Market Outlook
9.5 Latin America
9.5.1 Historical Market Trends
9.5.2 Market Outlook
10 Competitive Landscape
10.1 Market Structure
10.2 Key Player Profiles
10.2.1 Abbott Laboratories
10.2.2 AstraZeneca plc
10.2.3 B. Braun Medical Ltd
10.2.4 Dexcom, Inc
10.2.5 Eli Lilly and Company
10.2.6 Insulet Corporation
10.2.7 Janssen Pharmaceuticals Inc. (Johnson & Johnson)
10.2.8 LifeScan IP Holdings, LLC
10.2.9 Medtronic plc
10.2.10 Merck & Co. Inc.
10.2.11 Novo Nordisk A/S
10.2.12 Roche Diabetes Care, Inc (F. Hoffmann-La Roche AG)
10.2.13 Sanofi-Aventis U.S. LLC (Sanofi S.A.)
List of Figures
Figure 1: The Impact of Diabetes on the Human Body
Figure 2: Diabetes Complications
Figure 3: Global: Overweight & Obese Population (in Million), 2014, 2019 & 2025
Figure 4: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 5: Global: Breakup of Diabetes Patients by Region (in %), 2019 & 2025
Figure 6: Global: Total Number of Diabetes Patients (in Millions), 2018-2023
Figure 7: Global: Total Number of Diabetes Patients Forecast (in Millions), 2024-2032
Figure 8: Global (Type1 & Type2): Total Number of Diabetes Patients (in Millions), 2018-2023
Figure 9: Global (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Millions), 2024-2032
Figure 10: Global: Total Number of Diabetes Patients by Region (in Millions), 2018-2023
Figure 11: Global: Total Number of Diabetes Patients Forecast by Region (in Millions), 2024-2032
Figure 12: Global (Male & Female): Total Number of Diabetes Patients (in Millions), 2018-2023
Figure 13: Global (Male & Female): Total Number of Diabetes Patients Forecast (in Millions), 2024-2032
Figure 14: Global: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79, in Million), 2018-2023
Figure 15: Global: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79, in Million), 2024-2032
Figure 16: Global: Diabetes Drugs and Diagnostics Market: Major Drivers and Challenges
Figure 17: Global: Diabetes Drugs and Diagnostics Market: Value Trends (in Billion US$), 2018-2023
Figure 18: Global: Diabetes Drugs and Diagnostics Market: Breakup by Segment (in %), 2023
Figure 19: Global: Diabetes Drugs and Diagnostics Market: Breakup by Region (in %), 2023
Figure 20: Global: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Billion US$), 2024-2032
Figure 21: Global: Oral-Antidiabetics Market: Value Trends (in Million US$), 2018-2023
Figure 22: Global: Oral-Antidiabetics Market: Breakup by Class (in %), 2023
Figure 23: Global: Oral-Antidiabetics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 24: Global: Insulin Market: Value Trends (in Million US$), 2018-2023
Figure 25: Global: Insulin Market: Breakup by Class (in %), 2023
Figure 26: Global: Insulin Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 27: Global: Diabetes Diagnostics Market: Value Trends (in Million US$), 2018-2023
Figure 28: Global: Diabetes Diagnostics Market: Breakup by Product Type (in %), 2023
Figure 29: Global: Diabetes Diagnostics Market: Breakup by End-User (in %), 2023
Figure 30: Global: Diabetes Diagnostics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 31: North America: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2018-2023
Figure 32: North America: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 33: Europe: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2018-2023
Figure 34: Europe: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 35: Asia Pacific: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2018-2023
Figure 36: Asia Pacific: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 37: Middle East and Africa: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2018-2023
Figure 38: Middle East and Africa: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 39: Latin America: Diabetes Drugs and Diagnostics Market: Value Trends (in Million US$), 2018-2023
Figure 40: Latin America: Diabetes Drugs and Diagnostics Market Forecast: Value Trends (in Million US$), 2024-2032
Figure 41: Global: Diabetes Drugs and Diagnostics Industry: SWOT Analysis
Figure 42: Global: Diabetes Drugs and Diagnostics Industry: Value Chain Analysis
Figure 43: Global: Diabetes Drugs and Diagnostics Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: Global: Diabetes Drugs and Diagnostics Market: Industry Overview
Table 2: Diagnosis of Diabetes
Table 3: Global: Overweight & Obesity Statistics, 2005, 2010 & 2019
Table 4: Global: Diabetes Population Breakup by Region (in 000’s), 2019 & 2025
Table 5: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 6: Global: Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 7: Global (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 8: Global (Male & Female): Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 9: Global: Total Prevalence & Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79- in Million), 2018, 2023 & 2032
Table 10: Global: Diabetes Drugs and Diagnostics Market: Key Industry Highlights 2023 and 2032
Table 11: Global: Oral-Antidiabetics Market: Key Industry Highlights 2023 and 2032
Table 12: Global: Insulin Market: Key Industry Highlights 2023 and 2032
Table 13: Global: Diabetes Diagnostics Market: Key Industry Highlights 2023 and 2032
Purchase options
Benefits of Customization
Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-631-791-1145
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-713-2163
Email: sales@imarcgroup.com
Client Testimonials
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
Read More
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
Read More
Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.
Read More.webp)
We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.
Read More
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
Read More
The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.
Read More
My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.
Read More
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
Read More.webp){kind=logo}
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.
Read More
IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.
Read More